- €46.17bn
- €78.52bn
- €45.58bn
In Roundup litigation, a funny thing is happening on the way to forum selection (updated)
Bayer says no plans to restructure despite litigation threat
Bayer drops as BofA says glyphosate Missouri class moved to California court
Refile: Bayer to challenge transfer of Roundup settlement case to California federal court
Bayer falls as US glyphosate settlement deadline nears
Column: In Roundup litigation, a funny thing is happening on the way to forum selection
Brief: Bayer AG Says Phase II Aracog Head-To-Head Trial Met Its Primary Endpoint
Bayer’s Monsanto debacle sows bitter M&A lessons
Europe Research Roundup: Bayer, Ceres Power Holdings, EasyJet
Bayer sued for allegedly monopolizing US market for GMO corn seeds
Bayer sued for allegedly monopolizing US market for GMO corn seeds
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Olema Pharma climbs on collaboration agreement with Bayer
Bayer's $7.25 billion Roundup settlement faces new objections (updated)
Bayer's $7.25 billion Roundup settlement faces court objections
Brief: Bayer AG - Kerendia Approved In China For New Indication In Adult Patients With Heart Failure With LVEF ≥40%
OpenAI grows stable of law firms for high-stakes lawsuits, deals
Brief: Bayer’s Kerendia Granted Priority Review Of Supplemental New Drug Application By U.S. FDA
Brief: Bayer: U.S. FDA Grants Priority Review For Asundexian In Patients After Ischaemic Strokes